https://www.selleckchem.com/pr....oducts/ro-20-1724.ht
Sarma. Hepatectomy remains the most important treatment modality for most malignant liver tumors. Vascular involvement stays a reason for unresectability or major parenchymal resection. A possible way to avoid this is parenchymal-sparing hepatectomy (PSHX) with vascular resection and reconstruction (HVRR). In this article, we aim to demonstrate the specific role of this technique in avoiding post-hepatectomy liver failure (PHLF). A retrospective analysis of 10 patients who underwent HVRR was conducted. Technetium-mebrofenin hepatobil